CompassNow live for financial advisors
Viz.ai stock

Viz.ai Stock

HealthTech

Looking to sell Viz.ai stock or options?

Founded: 2016Funding to Date: $313.5Mhttps://www.viz.ai

Viz.ai develops an intelligent care coordination platform aimed at transforming global healthcare delivery. The platform utilizes advanced deep learning to promptly relay critical information about stroke patients directly to specialists for timely intervention. This technology enables healthcare providers to expedite treatment times and enhance access to care.

Notable investors include:
Greenoaks logo
Greenoaks logo
Insight Partners logo
GV logo
Kleiner Perkins logo
Other investors include:

HighGear Ventures, Camford Capital, Susa Ventures, AME Cloud Ventures, Seedcamp, Kevin Ding, Threshold Ventures, Jukka Jokinen, ARC Innovation Center, Halle Tecco.

Own Viz.ai stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure

Management Team

Manoj RamachandranCo-Founder
David GolanCo-Founder & Board Member
David KiznerChief Privacy Officer, Chief Legal and Administrative Officer & General Counsel
Jieun ChoeChief Operating Officer
Christopher Mansi MDCo-Founder, Chief Executive Officer & Board Member
William StadtlanderExecutive, Pharma and Medical Device & Vice President, Global Life Sciences Commercial
Steve SweenyChief Business Officer
Anne HellieSenior Director of Strategic Engagement
Eric LubbersVice President, Provider Sales - US
Michael HerringChief Financial Officer
Andrew M. IbrahimChief Clinical Officer
Timothy Showalter MDChief Medical Officer
Jallel HarratiChief Revenue Officer

Board Members

Mamoon HamidBoard Member
Rory O'DriscollBoard Member
Kevin DingBoard Member

Viz.ai’s stock FAQs

Viz.ai in the News

Source: Financial TimesViz.ai Wins 2025 Edison Award™ for Machine Learning Innovation for the Third Consecutive Year

The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.

Read more
Source: Financial ContentViz.ai Integrates Avicenna.AI's Tools for ASPECTS Stroke Severity Assessment and Incidental Pulmonary Embolism into Viz.ai One P...

Viz.ai Integrates Avicenna.AI's Tools for ASPECTS Stroke Severity Assessment and Incidental Pulmonary Embolism into Viz.ai One Platform

Read more
Source: Market ScreenerViz.ai to Participate in Morgan Stanley 22nd Annual Healthcare Conference

SAN FRANCISCO - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced Chris Mansi, MD, CEO and Co-founder, will present at the Morgan Stanley 22nd...

Read more
Source: 01netViz.ai and Medtronic Collaborate to Improve Post-Acute Stroke Patient Care in the United States

Collaboration aims to help cryptogenic stroke patients receive necessary cardiology follow-up to reduce risk of secondary strokeSAN FRANCISCO--(BUSINESS

Read more
Source: 01netViz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage

New AI algorithm enables precise and reliable quantification of intracerebral hemorrhage to make accurate and timely treatment decisionsSAN

Read more
Source: Medical Device NetworkViz.ai’s aneurysm diagnostic tool is 97.2% predictive in ruling out stroke

The AI-powered diagnostic platform can diagnose the presence of aneurysms by analysing computed tomography (CT) scans.

Read more